Abstract:C receptor type 1 (CR1, CD35) is present in a soluble form in plasma (sCR1). Soluble CR1 was measured with a specific ELISA assay in normal individuals and in patients with different diseases. The mean serum concentration of sCR1 in 31 normal donors was 31.4 +/- 7.8 ng/ml, and was identical in plasma. An increase in sCR1 was observed in 36 patients with end-stage renal failure on dialysis (54.8 +/- 11.7 ng/ml, p < 0.0001), and in 22 patients with liver cirrhosis (158.3 +/- 49.9 ng/ml, p < 0.0001). The mean sCR1 levels dropped from 181 +/- 62.7 to 52.1 +/- 24.0 ng/ml (p < 0.001) in nine patients who underwent liver transplantation, and was 33.5 +/- 7.3 in 10 patients with functioning renal grafts, indicating that the increase in sCR1 was reversible. Soluble CR1 was elevated in some hematologic malignancies (> 47 ng/ml), which included B cell lymphoma (12/19 patients), Hodgkin's lymphoma (4/4), and chronic myeloproliferative syndromes (4/5). By contrast, no increase was observed in acute myeloid or lymphoblastic leukemia (10) or myeloma (5). In two patients with chronic myeloproliferative syndromes, sCR1 decreased rapidly after chemotherapy. The mean concentration of sCR1 was not significantly modified in 181 HIV-infected patients at various stages of the disease (34.8 +/- 14.4 ng/ml), and in 13 patients with active SLE (38.3 +/- 19.6 ng/ml), although in both groups the number of CR1 was diminished on E. There was a weak but significant correlation between sCR1 and CR1 per E in HIV infection and SLE (r = 0.39, p < 0.0001, and r = 0.60, p < 0.03 respectively). In vitro, monocytes, lymphocytes, and neutrophils were found to release sCR1 into culture supernatants. In vivo, sCR1 was detected in the serum of SCID mice populated with human peripheral blood leukocytes. The sCR1 levels correlated with those of human IgG (r = 0.97, p < 0.0001), suggesting synthesis of sCR1 by the transferred lymphocytes. The mechanisms underlining the increased levels of sCR1 and its biologic consequences remain to be defined.

Interaction of C1q receptor with lung surfactant protein A

Interaction of C1q with the Receptor Calreticulin Requires a Conformational Change in C1q

Immunoregulatory function of SP-A

Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex.

Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro

Purinergic P2X7 receptor regulates lung surfactant secretion in a paracrine manner.

Structure and influence on stability and activity of the N-terminal propeptide part of lung surfactant protein C

Interaction of Rabbit C-reactive Protein with Phospholipid Monolayers at Air/water Interface

Regulation of MUC5AC Mucin Secretion by Depletion of AQP5 in SPC-A1 Cells

Purinergic P2X7 Receptor: A Pivotal Role in Surfactant Regulation?

C1q/MASP complexes – hybrid complexes of classical and lectin pathway proteins are found in the circulation

Specific interaction of rabbit C-reactive protein with phospholipid membranes

The Solvent at Antigen-Binding Site Regulated C3d-CR2 Interactions Through the C-terminal Tail of C3d at Different Ion Strengths: Insights from Molecular Dynamics Simulation.

[Regulation of Fc Receptor Expression by Immune Complexes on Neutrophils and U937 Cells].

TGF-beta1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes

Surfactant Protein A Inhibits Human Rhinovirus C Binding and Infection of Airway Epithelial Cells from Pediatric Asthma

Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes

Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity

Effect Of Surfactant Protein A On Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Expression In Human Proximal Tubular Epithelial Cells

Calcium-Dependent Binding of Rabbit C-Reactive Protein to Supported Lipid Monolayers Containing Exposed Phosphorylcholine Group

Functional roles of the lung surfactant proteins SP-A and SP-D in innate immunity